National practice patterns of proton versus photon therapy in the treatment of adult patients with primary brain tumors in the United States

References

• Kooy HM, Delaney TF. Proton and charged particle radiotherapy. Philadelphia (PA): Lippincott Williams & Wilkins, 2008.
   Google Scholar
• Wilson RR. Radiological use of fast protons. Radiology. 1946;47:487–491.
   PubMed Web of Science ®Google Scholar
• Jermann M. Particle therapy patient statistics [Particle Therapy Co-Operative Group website] Patient statistics per end of 2016 [cited 2018 May 15]. Available from: https://www.ptcog.ch/index.php/patient-statistics.
   Google Scholar
• Proton Therapy Centers. [The National Association for Proton Therapy website] [cited 2018 May 15]. Available from: http://www.proton-therapy.org/map.htm.
   Google Scholar
• Adeberg S, Harrabi SB, Verma V, et al. Treatment of meningioma and glioma with protons and carbon ions. Radiat Oncol. 2017;12:193.
   PubMed Web of Science ®Google Scholar
• Adeberg S, Bernhardt D, Harrabi SB, et al. Sequential proton boost after standard chemoradiation for high-grade glioma. Radiother Oncol. 2017;125:266–272.
   PubMed Web of Science ®Google Scholar
• Verma V, Rwigema JC, Malyapa RS, et al. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Radiother Oncol. 2017;125:21–30.
   PubMed Web of Science ®Google Scholar
• Chang JY, Verma V, Li M, et al. Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non–small cell lung cancer: final results of a phase 2 study. JAMA Oncol. 2017;3:e172032.
   PubMed Web of Science ®Google Scholar
• Rwigema JC, Verma V, Lin L, et al. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer. Cancer. 2017;123:4244.
   PubMed Web of Science ®Google Scholar
• Verma V, Iftekaruddin Z, Badar N, et al. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol. 2017;123:294–298.
   PubMed Web of Science ®Google Scholar
• Lin SH, Merrell KW, Shen J, et al. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol. 2017;123:376–381.
   PubMed Web of Science ®Google Scholar
• Verma V, Lin SH, Simone CB, et al. Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review. J Gastrointest Oncol. 2016;7:644.
   PubMed Web of Science ®Google Scholar
• Verma V, Moreno AC, Lin SH. Advances in radiotherapy management of esophageal cancer. J Clin Med. 2016;5:91.
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB, Wahl AO, et al. Proton radiotherapy for gynecologic neoplasms. Acta Oncol. 2016;55:1257–1265.
   PubMed Web of Science ®Google Scholar
• Chuong MD, Hallemeier CL, Jabbour SK, et al. Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys. 2016;95:488–497.
   PubMed Web of Science ®Google Scholar
• Verma V, Shah C, Mehta MP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer. 2016;16:145–154.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Farr JB. Proton beam therapy: a fad or a new standard of care. Curr Opin Pediatr. 2014;26:3–8.
   PubMed Web of Science ®Google Scholar
• Kopecky AS, Khan AJ, Pan W, et al. Outcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma: factors affecting proton therapy utilization. Adv Radiat Oncol. 2017;2:588–596.
   PubMedGoogle Scholar
• Porter AB, Lachance DH, Johnson DR. Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control. 2015;26:179–185.
   PubMed Web of Science ®Google Scholar
• Plascak JJ, Fisher JL. Area-based socioeconomic position and adult glioma: a hierarchical analysis of surveillance epidemiology and end results data. PLoS One. 2013;8:e60910.
   PubMed Web of Science ®Google Scholar
• Demers PA, Vaughan TL, Schommer RR. Occupation, socioeconomic status, and brain tumor mortality: a death certificate-based case-control study. J Occup Med. 1991;33:1001–1006.
   PubMedGoogle Scholar
• Deorah S, Lynch CF, Sibenaller ZA, et al. Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus. 2006;20:E1.
   PubMedGoogle Scholar
• Shen CJ, Hu C, Ladra MM, et al. Socioeconomic factors affect the selection of proton radiation therapy for children. Cancer. 2017;123:4048–4056.
   PubMed Web of Science ®Google Scholar
• Aizer AA, Ancukiewicz M, Nguyen PL, et al. Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer. 2014;120:238–243.
   PubMed Web of Science ®Google Scholar
• Sherwood PR, Dahman BA, Donovan HS, et al. Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol. 2011;101:67–74.
   PubMed Web of Science ®Google Scholar
• Deb S, Pendharkar AV, Schoen MK, et al. The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas. J Neurooncol. 2017;132:447–453.
   PubMed Web of Science ®Google Scholar
• Kasl RA, Brinson PR, Chambless LB. Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme. Surg Neurol Int. 2016;7:282.
   Google Scholar
• Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of Commission on Cancer–approved and–nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27:4177–4181.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–690.
   PubMed Web of Science ®Google Scholar
• Moreno AC, Verma V, Hofstetter WL, et al. Patterns of care and treatment outcomes of elderly patients with stage I esophageal cancer: analysis of the National Cancer Data Base. J Thorac Oncol. 2017;12:1152–1160.
   PubMed Web of Science ®Google Scholar
• Stahl JM, Corso CD, Verma V, et al. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer. 2017;103:11–16.
   PubMed Web of Science ®Google Scholar
• Verma V, McMillan MT, Grover S, et al. Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥5 centimeter) non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;97:146–154.
   PubMed Web of Science ®Google Scholar
• Lerro CC, Robbins AS, Phillips JL, et al. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20:1759–1765.
   PubMed Web of Science ®Google Scholar
• Mohanty S, Bilimoria KY. Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol. 2014;109:629–630.
   PubMed Web of Science ®Google Scholar
• Vogel J, Lin L, Litzky LA, et al. Predicted rate of secondary malignancies following adjuvant proton versus photon radiation therapy for thymoma. Int J Radiat Oncol Biol Phys. 2017;99:427–433.
   PubMed Web of Science ®Google Scholar
• Simone CB, Kramer K, O’Meara WP, et al. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma. Int J Radiat Oncol Biol Phys. 2012;82:242–249.
   PubMed Web of Science ®Google Scholar
• Harrabi SB, Bougatf N, Mohr A, et al. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther Onkol. 2016;192:759–769.
   PubMed Web of Science ®Google Scholar
• Stick LB, Yu J, Maraldo MV, et al. Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2017;97:754–761.
   PubMed Web of Science ®Google Scholar
• Amini A, Raben D, Crawford ED, et al. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: a study of the National Cancer Database. Urol Oncol. 2017;35:438–446.
   PubMed Web of Science ®Google Scholar
• Particle therapy facilities in operation [Particle Therapy Co-Operative Group website] April 2018 [cited 2018 May 15]. Available from: https://www.ptcog.ch/index.php/facilities-in-operation
   Google Scholar
• Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol. 2002;20:1635–1642.
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820.
   PubMed Web of Science ®Google Scholar
• Wesseling P, Capper D. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 2018;44:139–150.
   PubMed Web of Science ®Google Scholar
• Yu JB, Soulos PR, Herrin J, et al. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst. 2013;105:25–32.
   PubMedGoogle Scholar
• Ojerholm E, Hill-Kayser CE. Insurance coverage decisions for pediatric proton therapy. Pediatr Blood Cancer. 2018;65:e26827.
   Web of Science ®Google Scholar
• Shah A, Ricci KI, Efstathiou JA. Beyond a moonshot: insurance coverage for proton therapy. Lancet Oncol. 2016;17:559–561.
   PubMed Web of Science ®Google Scholar
• Verma V, Shah C, Rwigema JC, et al. Cost-comparativeness of proton versus photon therapy. Chin Clin Oncol. 2016;5:56.
   PubMed Web of Science ®Google Scholar
• Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016;122:1483–1501.
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB, Mishra MV. Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review. J Natl Cancer Inst. 2018;110:341–353.
   Google Scholar